ANGELLINE (SCOTLAND) LTD.Active
Key figures
Like most small UK companies, ANGELLINE (SCOTLAND) LTD. does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £2,000 (1% of the profit for the year).
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | — | — | — |
| Total assets | — | — | — | — | — |
| Total liabilities | — | — | — | — | 8,956,024 |
| Net assets / total equity | 160,317 | 215,244 | 221,289 | 221,164 | 228,980 |
| Average number of employees | 0 | 0 | 0 | 0 | 0 |
| Dividends paid | — | — | — | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: ANGELLINE (SCOTLAND) LTD.
Company
ANGELLINE (SCOTLAND) LTD. is a private limited company registered with Companies House under company number SC385592. It was incorporated on 17 Sep 2010. Its status is active. The registered office is in Kilmacolmkilmacolm (PA13). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730), retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749), retail sale of cosmetic and toilet articles in specialised stores (47750).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Aug 2025); the company files small company accounts (filleted). Net assets were £228,980, up 3.5% on the previous year. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered. 4 of 5 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 May 2027. The next confirmation statement is due by 5 Aug 2027.